Your doctor might also give you AFSTYLA before surgical procedures. On-demand treatment and control of bleeding episodes.
Prescribing Information Afstyla Antihemophilic Factor Recombinant Single Chain
Afstyla is a preservative-free sterile non-pyrogenic lyophilized powder to be reconstituted with sterile water for injection sWFI for intravenous injection.
Afstyla prescribing information. AFSTYLA Antihemophilic Factor Recombinant Single Chain is used to treat and control bleeding episodes in people with hemophilia A. King of Prussia PA. It is given as a shot into a vein.
The injection is given into a vein over several minutes. And the perioperative management of bleeding. Ensure that the AFSTYLA vial and diluent vial are at room temperature.
AFSTYLA is indicated in adults and children with hemophilia A for routine prophylaxis to reduce the frequency of bleeding episodes. Wash your hands before and after use. Used regularly prophylaxis AFSTYLA can reduce the number of bleeding episodes and the risk of joint damage due to bleeding.
AFSTYLA is expected to be available early this summer. J Thromb and Haemost 2018 16 555564. Haemophilia 2014 20 294300.
AFSTYLA can be self-administered or administered by a caregiver with training and approval from a healthcare provider or hemophilia treatment center. Use Afstyla antihemophilic factor recombinant afstyla as ordered by your doctor. FULL PRESCRIBING INFORMATION WARNING.
The chromogenic assay result most accurately reflects the clinical hemostatic potentialof AFSTYLA. AFSTYLA is for intravenous use only. Used regularly prophylaxis AFSTYLA can reduce the number of bleeding episodes and the risk of joint damage due to bleeding.
Follow all instructions closely. Afstyla is available in single-use vials containing the labeled amount of Factor VIII activity expressed in IU. AFSTYLA can be self-administered or administered by a caregiver with training and approval from a healthcare provider or hemophilia treatment center.
Read all information given to you. If severe hypercholesterolaemia andor hypertriglyceridaemia recur despite maximal lipid-lowering therapyb in accordance with respective prescribing information reduce lorlatinib by 1 dose level. If you will be giving yourself the shot your doctor or nurse will teach you how to give the shot.
AFSTYLA Antihemophilic Factor Recombinant Single Chain is used to treat and control bleeding episodes in people with hemophilia A. 21 Dose 22 Preparation and Reconstitution 23 Administration 3 DOSAGE FORMS AND STRENGTHS. Haemophilia 2016 22 957965.
AFSTYLA Important Safety Information AFSTYLA Antihemophilic Factor Recombinant Single Chain is used to treat and control bleeding episodes in people with hemophilia A. THROMBOTIC MICROANGIOPATHY AND THROMBOEMBOLISM Cases of thrombotic microangiopathy and thrombotic events were reported when on average a cumulative amount of 100 Ukg24 hours of activated prothrombin complex concentrate was administered for 24 hours or more to patients receiving HEMLIBRA. Afstyla is available as a powder and solvent used to make a solution for injection.
Your doctor might also give you AFSTYLA before surgical. AFSTYLA is for intravenous use only. CONTENTS 1 INDICATIONS AND USAGE 2 DOSAGE AND ADMINISTRATION.
Antihemophilic factor VIII recombinant. Each vial contains nominally 250 500 1000 1500 2000 2500 or 3000 IU of Afstyla. Haemophilia 2019 254 708-717.
ST Ledger et al. 53 Monitoring Laboratory Tests. PI prescribing Information.
Central nervous system effects comprises psychotic effects and changes in cognition mood mental status or speech. Monitor plasma Factor VIII activity in patients receiving AFSTYLA using either the chromogenic assay or the one -stage clotting assay which is routinely used in US clinical laboratories. The dose and frequency of the injections depend on whether Afstyla is used to treat or prevent bleeding the severity of the patients factor VIII deficiency the extent and location of the bleeding and the.
Pharmacy Clinical Policy Bulletins are developed by Aetna to assist in administering plan benefits and. AFSTYLA Antihemophilic Factor Recombinant Single Chain is indicated in adults and children with hemophilia A congenital Factor VIII deficiency for. Prepare and administer using aseptic technique.
Afstyla Factor 8 Recombinant Antihemophilic Factor 3000 Iu Range Vial
Efficacy In Bleed Control Afstyla Antihemophilic Factor Recombinant Single Chain
Https Www Ema Europa Eu En Documents Product Information Afstyla Epar Product Information En Pdf
These Highlights Do Not Include All The Information Needed To Use Afstyla Safely And Effectively See Full Prescribing Information For Afstyla Afstyla Antihemophilic Factor Recombinant Single Chain Lyophilized Powder For Solution For
Dosing Information And Taking Afstyla Afstyla Antihemophilic Factor Recombinant Single Chain
Https Www Fda Gov Media 140189 Download
Dosing Afstyla Antihemophilic Factor Recombinant Single Chain
Pharmacokinetics Afstyla Antihemophilic Factor Recombinant Single Chain
Frontiers Status Of Recombinant Factor Viii Concentrate Treatment For Hemophilia A In Italy Characteristics And Clinical Benefits Medicine
These Highlights Do Not Include All The Information Needed To Use Afstyla Safely And Effectively See Full Prescribing Information For Afstyla Afstyla Antihemophilic Factor Recombinant Single Chain Lyophilized Powder For Solution For
2
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.